Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (45)
  • 2024 (26)
  • 2023 (47)
  • 2022 (136)
  • 2021 (162)
  • 2020 (53)
  • 2019 (75)
  • 2018 (41)
  • 2017 (37)
  • 2016 (47)
  • 2015 (42)
  • 2014 (54)
  • 2013 (64)
  • 2012 (18)
  • 2011 (67)
  • 2008 (10)
  • 2007 (18)
  • 2006 (23)
  • 2005 (15)
  • 2004 (13)
  • 2003 (23)

Subject

  • Drug Trafficking (240)
  • Synthetic drugs (190)
  • Seizures (Drugs/Property) (184)
  • Task Forces/Task Force Officers (168)
  • Major Law Enforcement Operation (137)
  • Guns/Weapons (103)
  • OCDETF/Task Force (86)
  • Overdose (71)
  • Arrests/Convictions - Major (67)
  • Prescription Drugs (66)
  • Fake Pills (63)
  • Gangs (51)
  • Outreach/Drug Prevention (49)
  • Pharmaceuticals/Pharmacists/Physicians (44)
  • Diversion Division (42)
  • Narcoterrorism (41)
  • Take Back Day (36)
  • Press Conferences (32)
  • Guilty Plea (31)
  • Public and Media Affairs - also see Congressional Affairs (26)
  • Money Laundering (23)
  • One Pill Can Kill (18)
  • Fentanyl Awareness (17)
  • Prevention/Education - DEA websites GSAD, JTT etc (15)
  • Congressional Affairs (12)
  • HIDTA (10)
  • International/Foreign Operations (10)
  • Red Ribbon (9)
  • Dark Web- Internet Trafficking (8)
  • Extraditions (7)
  • Intergovernmental Affairs (6)
  • Asset Forfeiture (5)
  • Critical Incident (3)
  • Museum and Visitors Center (3)
  • Terrorism (3)
  • Fentanyl Free America (2)
  • Intelligence Division - Intelligence Products (2)
  • Scam Calls (2)
  • Campaigns (1)
  • Counterfeit Pills (1)
  • Other (1)

Drug Name

  • Fentanyl (195)
  • Cocaine (138)
  • Heroin (107)
  • Synthetic Opioids (89)
  • Methamphetamine (73)
  • Opioids (60)
  • Oxycodone (28)
  • Marijuana (Cannabis) (21)
  • Hydromorphone (7)
  • Benzodiazepines (6)
  • Ecstasy/MDMA (5)
  • Morphine (5)
  • K2/Spice (4)
  • Steroids (4)
  • Marijuana Concentrates (3)
  • Ketamine (2)
  • Methadone (2)
  • Synthetic Bath Salts or Designer Cathinones (2)
  • Amphetamines (1)
  • GHB (1)
  • Psilocybin (1)
  • Xylazine (1)

Field Division

  • New England (2349)
  • New York (1519)
  • Houston (893)
  • San Francisco (842)
  • Miami (826)
  • St. Louis (808)
  • Seattle (801)
  • Atlanta (763)
  • Chicago (622)
  • New Jersey (493)
  • New Orleans (470)
  • Detroit (360)
  • El Paso (346)
  • Dallas (315)
  • Los Angeles (299)
  • Phoenix (272)
  • San Diego (244)
  • Rocky Mountain (165)
  • Philadelphia (140)
  • Omaha (134)
  • Caribe (79)
  • Louisville (78)
  • Caribe (1)
  • Washington, DC (613)
  • Sede (408)
Clear All Results
PRESS RELEASE

DEA Holds Second Annual Family Summit on Fentanyl

Septiembre 28, 2023
WASHINGTON – On September 25 and 26, the U.S. Drug Enforcement Administration hosted the second annual DEA Family Summit on Fentanyl for families from across the country who have experienced the profound loss of a child due to a drug poisoning. U.S. Attorney General Merrick B. Garland and DEA Administrator...
Septiembre 28, 2023
PRESS RELEASE

19 Arrested on Federal Charges Trafficking Meth, Fentanyl, Heroin, and Cocaine in Charlottesville, VA

Septiembre 07, 2023
CHARLOTTESVILLE, Va. – A federal grand jury in Charlottesville, Virginia has indicted 17 individuals as part of a large-scale drug conspiracy that distributed more than 500 grams of methamphetamine, fentanyl, heroin, and cocaine in and around the Charlottesville region. The 37-count indictment, returned under seal August 29, 2023, partially unsealed...
Septiembre 07, 2023
PRESS RELEASE

DEA Washington Division Encourages Back to School Drug Awareness and Education

Septiembre 05, 2023
WASHINGTON, D.C. – As students return to school across the DMV, the DEA's Washington Division urges families to have open conversations about the dangers of drug experimentation and use. “Our citizens, especially our youth, are being exposed to an illicit drug supply that is more dangerous than ever before, making...
Septiembre 05, 2023
PRESS RELEASE

DEA Recognizes National Fentanyl Prevention and Awareness Day with Extended Hours for the Faces of Fentanyl Exhibit

Agosto 17, 2023
WASHINGTON – The Drug Enforcement Administration recognizes National Fentanyl Prevention and Awareness Day by joining the dedicated voices who continue to raise awareness in an effort to prevent the fentanyl poisonings devastating families across the country. On Monday, August 21 the DEA Museum will open with extended hours from 6...
Agosto 17, 2023
PRESS RELEASE

DEA Hosts Public Listening Sessions on Telemedicine Regulations

Agosto 07, 2023
WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available...
Agosto 07, 2023
PRESS RELEASE

Consent Decree Approved Among the U.S. and Cumberland, M.D. based Pharmacy and Pharmacist

Julio 06, 2023
Baltimore, Maryland - U.S. District Judge Lydia K. Griggsby approved the United States’ consent decree with John A. Beckman, a Cumberland, Maryland based pharmacist, and Beckman’s Greene Street Pharmacy, Inc. (“Beckman’s Pharmacy”), resolving the United States’ civil allegations that Beckman and Beckman’s Pharmacy violated the Controlled Substances Act (“CSA”) in...
Julio 06, 2023
PRESS RELEASE

Indictment Charges Alleged Members of Drug Trafficking Organization in Drug, Gun and Money Laundering Charges

Junio 27, 2023
WASHINGTON – This morning, law enforcement agents from the Metropolitan Police Department (MPD), Drug Enforcement Administration (DEA), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), Federal Bureau of Investigation (FBI), and the Internal Revenue Service Criminal Investigation (IRS-CI) arrested 12 alleged members of a violent drug trafficking organization (“DTO”), known...
Junio 27, 2023
PRESS RELEASE

The United States and Montgomery County Based Pharmacy and Pharmacist Reach a Consent Decree Over Allegations of Illegally Dispensed Controlled Substances

Mayo 31, 2023
Greenbelt, Maryland - U.S. District Judge Peter J. Messitte approved the United States’ consent decree with Abtin Youssefi-Rashti, a Montgomery County based pharmacist, and Upton Care Pharmacy, Inc. (“Upton Care”), resolving the United States’ civil allegations that Youssefi-Rashti and Upton Care violated the Controlled Substances Act (“CSA”) in illegally dispensing...
Mayo 31, 2023
PRESS RELEASE

Communities Across the Country Remove Nearly 664,000 Pounds of Unneeded Prescription Medications to Prevent Drug Misuse

Mayo 15, 2023
WASHINGTON – On April 22, 2023, DEA and its law enforcement partners came together once again to protect our communities from prescription misuse by safely disposing of 663,725 pounds of unneeded medications at nearly 5,000 collection sites across the country. Since its inception in 2010, DEA’s bi-annual National Prescription Take...
Mayo 15, 2023
PRESS RELEASE

DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for Six Months While Considering Comments from the Public

Mayo 09, 2023
WASHINGTON – Today, ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities...
Mayo 09, 2023
Showing 81 - 90 of 1016 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 5
  • Página 6
  • Página 7
  • Página 8
  • Current page 9
  • Página 10
  • Página 11
  • Página 12
  • Página 13
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster